Hemoglobin A1c levels in children with asthma using low dose inhaled corticosteroids

Indian Pediatrics

Volumn 46, Issue 4, 2009, Pages 300-303

  Yücel, Oya ^a,c   Eker, Yesim ^b   Nuhoglu, Cagatay ^b   Ceran, Omer ^b  

^a BASKENT UNIVERSITY   (Turkey)

^b HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^c NONE   (Turkey)

Author keywords

Bronchial asthma; Children; Corticosteroids

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; FLUTICASONE PROPIONATE; HEMOGLOBIN A1C;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG SAFETY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SEX DIFFERENCE; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ASTHMA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE;

EID: 66249091223     PISSN: 00196061     EISSN: 00196061     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma update on selected topics-2002. J Allergy Clin Immunol 2002; 110: 141-219.
2. The Childhood Asthma Management Program Research Group.The Childhood Asthma Management Program (CAMP): design, rationale, and methods. Control Clin Trials 1999; 20: 91-120.
3. Global Initative for Asthma (GINA). Workshop report, global strategy for asthma management and prevention (updated November 2006). Available at: http://www.ginasthma.com/Guidelineitem.asp?l1=2&l2=1&intId=60. Accessed April 20, 2007.
4. Allen DB. Systemic effects of inhaled corticosteroids in children. Curr Opin Pediatr 2004; 16: 440-444. (Pubitemid 39006494)
5. Eldeirawi K, Lipton RB. Predictors of hemoglobin A1c in a National Sample of Nondiabetic Children. The Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 2003; 157: 624-632.
6. Osterman-Golkar SM, Vesper HW. Assessment of the relationship between glucose and A1c using kinetic modeling. J Diab Comp 2006; 20: 285-294. (Pubitemid 44292530)
7. Brutsche MH, Brutsche IC, Munawar M, Langley SJ, Masterson CM, Daley-yates PT, et al. Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study. Lancet 2000; 356: 556-561.
8. Drake AJ, Howells RJ, Shield JPH, Prendiville A, Wards PS, Crowne EC. Symptomatic adrenal insufficiency presenting with hypoglycaemia in asthmatic children with asthma receiving high dose inhaled fluticasone propionate. BMJ 2002; 324: 1081-1083. (Pubitemid 34492819)
9. Smith AP, Banks J, Buchanan K, Cheong B, Gunawardena KA. Mechanisms of abnormal glucose metabolism during the treatment of acute severe asthma. Q J Med 1992; 82: 71-80.
10. Sathiyapriya V, Bobby Z, Kumar SV, Selvaraj N, Parthibane V, Gupta S. Evidence for the role of lipid peroxides on glycation of hemoglobin and plasma proteins in non-diabetic asthma patients. Clin Chim Acta 2006; 366: 299-303. (Pubitemid 43330999)
11. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA1c, Analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25: 275-278.
12. Harrison TW. Systemic availability of inhaled budesonide and fluticasone propionate: healthy versus asthmatic lungs. Bio Drugs 2001; 15: 405-411. (Pubitemid 32738654)
13. Donnelly R, Seale JP. Clinical pharmacokinetics of inhaled budesonide. Clin Pharmacokinet 2001; 40: 427-440. (Pubitemid 32656079)
14. Wright NP, Wales JK. The incidence of hypoglycaemia in children with type 1 diabetes and treated asthma. Arch Dis Child 2003; 88: 155-156. (Pubitemid 36160647)
15. Dawson KP, Pena AC, Manglick P. Acute asthma, salbutamol and hyperglycaemia. Acta Pediatr 1995; 84: 305-307.